Connect with us

5 Top Penny Stocks To Watch Under $1 After CSCW Stock Explodes

There are so many traders looking for the best penny stocks 2021…
The post 5 Top Penny Stocks To Watch Under $1 After CSCW Stock Explodes appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Published

2 years ago

on

There are so many traders looking for the best penny stocks 2021 has to offer. Something that many are finding out, however, is that without a plan, you can get lost in the noise. With thousands of stocks hitting scanners and millions of traders giving their 2 cents, it can become difficult to focus. For this reason, understanding what your goals are is essential.

Are you looking to make money with penny stocks by day trading, or are you looking to invest for a longer term? Do you know how to handle volatility from cheap penny stocks, or are you more comfortable with higher prices? Timing is critical, and plotting where to enter and exit even before making the trade is a tremendous asset to have in your skillset.

In this article, we’re looking at 5 penny stocks trading under $1. Yes, they are accessible on platforms like Webull and other mobile-first brokers. However, if you don’t necessarily know how to handle fast-moving stocks, they can certainly present higher risk levels. One of the drivers of momentum among retail traders right now is daily themes.

Earlier today, we discussed short squeeze penny stocks. But you’ve also got sympathy momentum stemming from these low-priced stocks thanks to big breakouts from the likes of Color Star Technology (NASDAQ:CSCW) this week and echoes or big moves from former sub-$1 stocks like Camber Energy (NYSE:CEI) in September.

5 Penny Stocks Under $1 To Watch In November

  1. CohBar Inc. (NASDAQ:CWBR)
  2. Oragenics Inc. (NYSE:OGEN)
  3. Gran Tierra Energy (NYSE:GTE)
  4. Blue Hat Interactive (NASDAQ:BHAT)
  5. AIkido Pharma Inc. (NASDAQ:AIKI)

1. CohBar Inc. (NASDAQ:CWBR)

Shares of CWBR stock gained momentum this week thanks to some insider transactions and a new update from the company. The clinical-stage biotech focuses on treatments for chronic and age-related diseases. In particular, its mitochondria-based platform has targeted everything from nonalcoholic steatohepatitis and obesity to cancer and cardiovascular diseases.

Read more: 5 Penny Stocks To Watch For November With Potential Biotech Catalysts

This week, momentum initially triggered thanks to an insider purchase from director Misha Petkevich. The transaction was reported on November 1st but occurred on October 28. Petkevich bought 167,000 shares of CWBR stock at an average price of $0.5759. Coincidentally, this came just as the company announced it would be releasing its Q3 financials in a few weeks (Nov. 15). Whether or not the two have anything to do with one another is speculative. However, these two events have added some extra attention this week.

In addition to this, CohBar also announced a $15 million raise last week. The raise is expected to close ‘on or about” November 1, so this may be another topic of interest for the market right now. Whichever the case, CWBR stock continues attempting to mount a recovery following a big sell-off at the end of October that coincided with the news of that larger raise.

2. Oragenics Inc. (NYSE:OGEN)

One of the other popular trends in the stock market this week has to do with COVID-19. As more vaccines continue development and current offerings from the likes of Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) remain bellwethers for this niche, traders continue looking for sympathy stocks to watch.

Oragenics recently spiked during the second half of October. This was thanks, in part, to optimism surrounding new COVID treatments. Late last quarter, the company began its COVID-19 Challenge Study evaluating its SARS-CoV-2 vaccine candidate. Since then, no further updates have been given. However, the important thing to note is that results are expected this month.

According to Frederick W. Telling, Ph.D., Executive Chairman of Oragenics, “The findings from this second preclinical study will be a part of our Investigational New Drug filing to the U.S. Food and Drug Administration, expected to be made in the first quarter of 2022, to advance the most promising formulations into human clinical studies.”

As November begins, OGEN stock has quickly become one of the penny stocks to watch.

penny stocks under $1 to watch Oragenics Inc. OGEN stock chart

3. Gran Tierra Energy (NYSE:GTE)

Energy stocks also remain in focus heading into the final months of the year. Whether we’re talking about renewables or traditional energy sources like coal, oil, and gas, this niche in the stock market is a hot topic.

Gran Tierra is one of the penny stocks we’ve followed for months now. In fact, since late August, GTE stock has managed to rally more than 100%; and yes, it is still one of the penny stocks under $1 right now. The oil and gas exploration company is developing a portfolio of assets in Columbia and Ecuador. Thanks to industry momentum and more robust earnings growth, traders have continued following Gran Tierra’s progress.

Read more: Hot Reddit Penny Stocks to Watch That Exploded Today

Now, GTE stock is on watch ahead of its next round of results. These are set to come after the market closes on November 1. Just for some context, in its last earnings update, operational highlights included a 14% jump in average total production for the second quarter on a year-over-year basis. The company also reaffirmed its full-year production guidance of 27.5k to 28.5k barrels of oil per day with a capital program range of $130 million to $150 million.

penny stocks under $1 to watch Gran Tierra Energy GTE stock chart

4. Blue Hat Interactive (NASDAQ:BHAT)

Another trend that has gotten some attention recently is anything dealing with “Metaverse,” and thanks to Facebook’s (NASDAQ:FB) news last week, even companies with “Meta” in their name have gotten some attention. Color Star hasn’t been the only stock under $1 benefiting from this trend.

Blue Hat Interactive shares have also caught a jolt of trading action recently. The company’s involvement with augmented reality and interactive games has sparked some intrigue this month. You can also see this reflected on the BHAT stock chart. Shares jumped from lows of $0.5325 late last month to recent highs of over $0.85 last week.

The company’s recent earnings solidified a growth path for the company. Blue Hat highlighted a 269.6% increase in revenues for the first half of the year. The company also saw a 138.4% jump in gross profit over the previous year’s results. With AR/VR and metaverse stocks gaining ground, the biggest question to answer now, in my opinion, is how long can this trend last?

penny stocks under $1 to watch Blue Hat Interactive BHAT stock chart

5. AIkido Pharma Inc. (NASDAQ:AIKI)

Much like Blue Hat, AIkido Pharma may have also benefited from some sympathy sentiment recently. This stems from the excitement around alternative social media stocks like DatChat (NASDAQ:DATS) and the latest trend in EV stocks thanks to Tesla (NASDAQ:TSLA). While at its center, AIkido is a pharmaceutical company, the last few months have seen its model evolve. It has become more of an investment-focused firm looking to leverage its public listing as a means to create shareholder value through new investments.

DatChat was one of these such investments and has become a driving force in the retail trading arena for weeks. Shares of DATS stock jumped from an IPO low of $3.31 to highs of over $18, with current trading levels around $8. AIkido holds a stake in the company.

Now, the “Tesla” angle is a bit newer. AIkido has nothing to do with Elon Musk’s company. However, it did recently announce a secured interest in an electric truck maker, Tevva Motors. Company CEO Anthony Hayes described this newest deal as a “growth opportunity” that “represents an opportunity to partake in a rapidly expanding field, with the possibility of an exit in early 2022 as Tevva pursues a public listing…We are always looking to create shareholder value while limiting exposure in exciting and growing industries.  We hope this short-term opportunity becomes an asset for our shareholders, like DatChat.”

Thanks to this positioning and some speculative momentum, AIKI stock has managed s strong move since mid-September.

penny stocks under $1 to watch AIkido Pharma Inc AIKI stock chart

Should You Buy Penny Stocks Under $1?

Like most investments, penny stocks carry risk. When you fold in cheap stocks under $1, that risk can become compounded with the added volatility of big percentage swing from slight price changes. Understanding how to handle volatility is even more important, which is something the keep in mind if you’re looking for penny stocks to buy under $1.

The post 5 Top Penny Stocks To Watch Under $1 After CSCW Stock Explodes appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

Related Topics:
Continue Reading

Government

Student loan borrowers may finally get answers to loan forgiveness issues

A major student loan service company has been invited to face Congress over its alleged servicing failures.

Published

2 hours ago

on

March 19, 2024

By

U.S. Sen. Elizabeth Warren (D-MA) wants answers from one of the top student loan service companies in the country for allegedly botching its student loan forgiveness process involving the federal Public Service Loan Forgiveness program, leaving borrowers confused and without answers.

The senator sent a letter to Mohela CEO Scott Giles on March 18 inviting him to testify before Congress at a hearing on April 10 titled “MOHELA’s Performance as a Student Loan Servicer.” During the hearing, Giles will have to answer for why his company allegedly failed to send billing statements to student loan borrowers in a timely manner and miscalculated monthly payments for borrowers when it was time for them to repay their loans in September last year.

Related: Here's who qualifies for Biden's student loan debt relief starting next month

Also, in the letter, Warren highlighted a report that claimed that Mohela failed to perform basic servicing functions for borrowers eligible for PSLF, which led to over 800,000 public service workers facing delays in receiving student debt relief. The report also accuses the company of using a “‘call deflection’ scheme” to keep customers away from speaking to a customer service representative and instead redirecting them to parts of their website.

“Your company has contributed to student loan borrowers’ difficulties by mishandling borrowers’ return to repayment following the COVID-19 pandemic-related pause on payments, interest, and collections and by impeding public servants’ access to PSLF relief,” wrote Warren in the letter.

The move from Warren comes after the U.S. Department of Education withheld $7.2 million in payments to its servicer Mohela in October as punishment because it failed to issue timely billing statements to 2.5 million borrowers which resulted in 800,000 borrowers becoming delinquent on their loans. The department ordered Mohela to put those affected by the issues into forbearance until the mess was resolved.

U.S. President Joe Biden is joined by Education Secretary Miguel Cardona (L) as he announces new actions to protect borrowers after the Supreme Court struck down his student loan forgiveness plan in the Roosevelt Room at the White House on June 30, 2023 in Washington, DC. 

Chip Somodevilla/Getty Images

Mohela is also currently facing two class-action lawsuits, one filed in December last year and another in January this year, for its alleged “failure to timely process and render decisions for student loan borrowers enrolled in the Public Service Loan Forgiveness program.”

In response to recent criticism surrounding its alleged issues and failures regarding the PSLF program, Mohela claimed in a statement to the Missouri Independent that it “does not have authority to process loan forgiveness until authorization is provided by FSA, which can take months to occur.”

The company also claimed that there are “false accusations” inside of the bombshell report, which was released in February, that details the company’s servicing failures.

“It is unfortunate and irresponsible that information is being spun to create a false narrative in an attempt to mislead the public. False accusations are being disingenuously branded as an investigative report,” said Mohela. 

Related: Amazon just made a major announcement that will bring you big savings — and we have all the details

Read More

Continue Reading

Uncategorized

Another airline is making lounge fees more expensive

Qantas Airways is increasing the price of accessing its network of lounges by as much as 17%.

Published

2 hours ago

on

March 19, 2024

By

Over the last two years, multiple airlines have dealt with crowding in their lounges. While they are designed as a luxury experience for a small subset of travelers, high numbers of people taking a trip post-pandemic as well as the different ways they are able to gain access through status or certain credit cards made it difficult for some airlines to keep up with keeping foods stocked, common areas clean and having enough staff to serve bar drinks at the rate that customers expect them.

In the fall of 2023, Delta Air Lines  (DAL)  caught serious traveler outcry after announcing that it was cracking down on crowding by raising how much one needs to spend for lounge access and limiting the number of times one can enter those lounges.

Related: Competitors pushed Delta to backtrack on its lounge and loyalty program changes

Some airlines saw the outcry with Delta as their chance to reassure customers that they would not raise their fees while others waited for the storm to pass to quietly implement their own increases.

A photograph captures a Qantas Airways lounge in Sydney, Australia.

Shutterstock

This is how much more you'll have to pay for Qantas lounge access

Australia's flagship carrier Qantas Airways  (QUBSF)  is the latest airline to announce that it would raise the cost accessing the 24 lounges across the country as well as the 600 international lounges available at airports across the world through partner airlines.

More Travel:

Unlike other airlines which grant access primarily after reaching frequent flyer status, Qantas also sells it through a membership — starting from April 18, 2024, prices will rise from $600 Australian dollars ($392 USD)  to $699 AUD ($456 USD) for one year, $1,100 ($718 USD) to $1,299 ($848 USD) for two years and $2,000 AUD ($1,304) to lock in the rate for four years.

Those signing up for lounge access for the first time also currently pay a joining fee of $99 AUD ($65 USD) that will rise to $129 AUD ($85 USD).

The airline also allows customers to purchase their membership with Qantas Points they collect through frequent travel; the membership fees are also being raised by the equivalent amount in points in what adds up to as much as 17% — from 308,000 to 399,900 to lock in access for four years.

Airline says hikes will 'cover cost increases passed on from suppliers'

"This is the first time the Qantas Club membership fees have increased in seven years and will help cover cost increases passed on from a range of suppliers over that time," a Qantas spokesperson confirmed to Simple Flying. "This follows a reduction in the membership fees for several years during the pandemic."

The spokesperson said the gains from the increases will go both towards making up for inflation-related costs and keeping existing lounges looking modern by updating features like furniture and décor.

While the price increases also do not apply for those who earned lounge access through frequent flyer status or change what it takes to earn that status, Qantas is also introducing even steeper increases for those renewing a membership or adding additional features such as spouse and partner memberships.

In some cases, the cost of these features will nearly double from what members are paying now.

Read More

Continue Reading

Uncategorized

PR55α-controlled PP2A Inhibits p16 Expression and Blocks Cellular Senescence Induction

“Our results show that PR55α specifically reduces p16 expression […]” Credit: 2024 Palanivel et al. “Our results show that PR55α specifically…

Published

2 hours ago

on

March 19, 2024

By

“Our results show that PR55α specifically reduces p16 expression […]”

Credit: 2024 Palanivel et al.

“Our results show that PR55α specifically reduces p16 expression […]”

BUFFALO, NY- March 19, 2024 – A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 16, Issue 5, entitled, “PR55α-controlled protein phosphatase 2A inhibits p16 expression and blocks cellular senescence induction by γ-irradiation.”

Cellular senescence is a permanent cell cycle arrest that can be triggered by both internal and external genotoxic stressors, such as telomere dysfunction and DNA damage. The execution of senescence is mainly by two pathways, p16/RB and p53/p21, which lead to CDK4/6 inhibition and RB activation to block cell cycle progression. While the regulation of p53/p21 signaling in response to DNA damage and other insults is well-defined, the regulation of the p16/RB pathway in response to various stressors remains poorly understood. 

In this new study, researchers Chitra Palanivel, Lepakshe S. V. Madduri, Ashley L. Hein, Christopher B. Jenkins, Brendan T. Graff, Alison L. Camero, Sumin Zhou, Charles A. Enke, Michel M. Ouellette, and Ying Yan from the University of Nebraska Medical Center report a novel function of PR55α, a regulatory subunit of PP2A Ser/Thr phosphatase, as a potent inhibitor of p16 expression and senescence induction by ionizing radiation (IR), such as γ-rays. 

“During natural aging, there is a gradual accumulation of p16-expressing senescent cells in tissues [76]. To investigate the significance of PR55α in this up-regulation of p16, we compared levels of the p16 and PR55α proteins in a panel of normal tissue specimens derived from young (≤43 y/o) and old (≥68 y/o) donors.”

The results show that ectopic PR55α expression in normal pancreatic cells inhibits p16 transcription, increases RB phosphorylation, and blocks IR-induced senescence. Conversely, PR55α-knockdown by shRNA in pancreatic cancer cells elevates p16 transcription, reduces RB phosphorylation, and triggers senescence induction after IR. Furthermore, this PR55α function in the regulation of p16 and senescence is p53-independent because it was unaffected by the mutational status of p53. Moreover, PR55α only affects p16 expression but not p14 (ARF) expression, which is also transcribed from the same CDKN2A locus but from an alternative promoter. In normal human tissues, levels of p16 and PR55α proteins were inversely correlated and mutually exclusive. 

“Collectively, these results describe a novel function of PR55α/PP2A in blocking p16/RB signaling and IR-induced cellular senescence.”
 

Read the full paper: DOI: https://doi.org/10.18632/aging.205619 

Corresponding Authors: Michel M. Ouellette, Ying Yan

Corresponding Emails: mouellet@unmc.edu, yyan@unmc.edu

Keywords: p16, p14, CDKN2A locus, p53, RB, PR55α, PP2A, γ-irradiation

Click here to sign up for free Altmetric alerts about this article.

 

About Aging:

Aging publishes research papers in all fields of aging research including but not limited, aging from yeast to mammals, cellular senescence, age-related diseases such as cancer and Alzheimer’s diseases and their prevention and treatment, anti-aging strategies and drug development and especially the role of signal transduction pathways such as mTOR in aging and potential approaches to modulate these signaling pathways to extend lifespan. The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases, prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.

Aging is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed Central, Web of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Please visit our website at www.Aging-US.com​​ and connect with us:

  • Facebook
  • X, formerly Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Reddit
  • Pinterest
  • Spotify, and available wherever you listen to podcasts

 

Click here to subscribe to Aging publication updates.

For media inquiries, please contact media@impactjournals.com.

 

Aging (Aging-US) Journal Office

6666 E. Quaker Str., Suite 1B

Orchard Park, NY 14127

Phone: 1-800-922-0957, option 1

###

Journal

Aging-US

DOI

10.18632/aging.205619

Method of Research

Experimental study

Subject of Research

Cells

Article Title

PR55α-controlled protein phosphatase 2A inhibits p16 expression and blocks cellular senescence induction by γ-irradiation

Article Publication Date

4-Mar-2024

Read More

Continue Reading

Trending